EGFR and neoplasm: Conversely, in the Osi group, the prognostic role of VEGFR2 and VEGF‐C expression was slightly different based on EGFR mutation status; therefore, information regarding the protein expression of VEGF within tumor cells may be useful to suppress resistance to osimertinib for the choice of add‐on VEGF inhibitors.